These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29725676)

  • 41. Alzheimer peptides aggregate into transient nanoglobules that nucleate fibrils.
    Luo J; Wärmländer SK; Gräslund A; Abrahams JP
    Biochemistry; 2014 Oct; 53(40):6302-8. PubMed ID: 25198136
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preventing amyloid-β oligomerization and aggregation with berberine: Investigating the mechanism of action through computational methods.
    Qais FA; Parveen N; Afzal M; Furkan M; Khan RH
    Int J Biol Macromol; 2024 Feb; 258(Pt 2):128900. PubMed ID: 38128802
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Amyloid peptide Aβ40 inhibits aggregation of Aβ42: evidence from molecular dynamics simulations.
    Viet MH; Li MS
    J Chem Phys; 2012 Jun; 136(24):245105. PubMed ID: 22755606
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular dynamics simulations to investigate the aggregation behaviors of the Abeta(17-42) oligomers.
    Zhao JH; Liu HL; Liu YF; Lin HY; Fang HW; Ho Y; Tsai WB
    J Biomol Struct Dyn; 2009 Feb; 26(4):481-90. PubMed ID: 19108587
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In silico investigation on the inhibition of Aβ
    Dutta M; Mattaparthi VSK
    J Biomol Struct Dyn; 2018 Feb; 36(3):741-752. PubMed ID: 28278027
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interactions of Aβ25-35 β-barrel-like oligomers with anionic lipid bilayer and resulting membrane leakage: an all-atom molecular dynamics study.
    Chang Z; Luo Y; Zhang Y; Wei G
    J Phys Chem B; 2011 Feb; 115(5):1165-74. PubMed ID: 21192698
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Arginine metabolising enzymes as targets against Alzheimers' disease.
    Whiteley CG
    Neurochem Int; 2014 Feb; 67():23-31. PubMed ID: 24508404
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular Mechanisms of Alzheimer's Biomarker FDDNP Binding to Aβ Amyloid Fibril.
    Parikh ND; Klimov DK
    J Phys Chem B; 2015 Sep; 119(35):11568-80. PubMed ID: 26237080
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modulation of Amyloid β-Protein (Aβ) Assembly by Homologous C-Terminal Fragments as a Strategy for Inhibiting Aβ Toxicity.
    Li H; Rahimi F; Bitan G
    ACS Chem Neurosci; 2016 Jul; 7(7):845-56. PubMed ID: 27322435
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bacterial inclusion bodies of Alzheimer's disease β-amyloid peptides can be employed to study native-like aggregation intermediate states.
    Dasari M; Espargaro A; Sabate R; Lopez del Amo JM; Fink U; Grelle G; Bieschke J; Ventura S; Reif B
    Chembiochem; 2011 Feb; 12(3):407-23. PubMed ID: 21290543
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of all-atom force fields on amyloid oligomerization: replica exchange molecular dynamics simulations of the Aβ(16-22) dimer and trimer.
    Nguyen PH; Li MS; Derreumaux P
    Phys Chem Chem Phys; 2011 May; 13(20):9778-88. PubMed ID: 21487594
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structures of Aβ17-42 trimers in isolation and with five small-molecule drugs using a hierarchical computational procedure.
    Chebaro Y; Jiang P; Zang T; Mu Y; Nguyen PH; Mousseau N; Derreumaux P
    J Phys Chem B; 2012 Jul; 116(29):8412-22. PubMed ID: 22283547
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanistic insights into the size-dependent effects of nanoparticles on inhibiting and accelerating amyloid fibril formation.
    John T; Adler J; Elsner C; Petzold J; Krueger M; Martin LL; Huster D; Risselada HJ; Abel B
    J Colloid Interface Sci; 2022 Sep; 622():804-818. PubMed ID: 35569410
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tabersonine inhibits amyloid fibril formation and cytotoxicity of Aβ(1-42).
    Kai T; Zhang L; Wang X; Jing A; Zhao B; Yu X; Zheng J; Zhou F
    ACS Chem Neurosci; 2015 Jun; 6(6):879-88. PubMed ID: 25874995
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The molecular structure of Alzheimer β-amyloid fibrils formed in the presence of phospholipid vesicles.
    Niu Z; Zhao W; Zhang Z; Xiao F; Tang X; Yang J
    Angew Chem Int Ed Engl; 2014 Aug; 53(35):9294-7. PubMed ID: 24810551
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Computational approach for the assessment of inhibitory potency against beta-amyloid aggregation.
    Bajda M; Filipek S
    Bioorg Med Chem Lett; 2017 Jan; 27(2):212-216. PubMed ID: 27914799
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interaction Dynamics in Inhibiting the Aggregation of Aβ Peptides by SWCNTs: A Combined Experimental and Coarse-Grained Molecular Dynamic Simulation Study.
    Lin D; Qi R; Li S; He R; Li P; Wei G; Yang X
    ACS Chem Neurosci; 2016 Sep; 7(9):1232-40. PubMed ID: 27441457
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Insights into the Interaction Mechanism of Ligands with Aβ42 Based on Molecular Dynamics Simulations and Mechanics: Implications of Role of Common Binding Site in Drug Design for Alzheimer's Disease.
    Kundaikar HS; Degani MS
    Chem Biol Drug Des; 2015 Oct; 86(4):805-12. PubMed ID: 25763767
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mechanism of C-Terminal Fragments of Amyloid β-Protein as Aβ Inhibitors: Do C-Terminal Interactions Play a Key Role in Their Inhibitory Activity?
    Zheng X; Wu C; Liu D; Li H; Bitan G; Shea JE; Bowers MT
    J Phys Chem B; 2016 Mar; 120(8):1615-23. PubMed ID: 26439281
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Disordered versus fibril-like amyloid β (25-35) dimers in water: structure and thermodynamics.
    Kittner M; Knecht V
    J Phys Chem B; 2010 Nov; 114(46):15288-95. PubMed ID: 20964446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.